特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

放射性医薬品の世界市場:2020年-2024年

Global Radiopharmaceuticals Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 945143
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
放射性医薬品の世界市場:2020年-2024年 Global Radiopharmaceuticals Market 2020-2024
出版日: 2020年06月24日 ページ情報: 英文 120 Pages
概要

放射性医薬品市場は2020年から2024年の間に10%のCAGRで推移して、2024年までに35億8,000万米ドル成長する見込みです。同市場は、癌症例の増加、腫瘍学市場への投資の増加、および利益と比較して放射性医薬品の副作用が最小限であることによって推進されています。

当レポートでは、放射性医薬品市場を調査し、市場概要、市場の成長要因および阻害要因の分析、タイプ別・地域別の市場規模の推移と予測、ベンダー分析、市場機会など、包括的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

用途別市場セグメンテーション

  • マーケット・セグメント
  • 用途別比較
  • 診断-市場規模と予測(2019年-2024年)
  • 治療薬-市場規模と予測(2019年-2024年)
  • 用途別の市場機会

顧客情勢

  • 顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米 -市場規模と予測(2019年-2024年)
  • 欧州-市場規模と予測(2019年-2024年)
  • アジア太平洋-市場規模と予測(2019年-2024年)
  • 南米 -市場規模と予測(2019年-2024年)
  • 中東・アフリカ-市場規模と予測(2019年-2024年)
  • 主要国
  • 地域の市場機会
  • 市場成長要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • ベンダー情勢
  • 創造的破壊の状況

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Bayer AG
  • BWX Technologies Inc.
  • Cardinal Health Inc.
  • Curium
  • Eckert & Ziegler AG
  • Eli Lilly and Co.
  • General Electric Co.
  • Lantheus Holdings Inc.
  • Novartis AG
  • Siemens Healthineers AG

付録

目次
Product Code: IRTNTR43963

Technavio has been monitoring the radiopharmaceuticals market and it is poised to grow by $ 3.58 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising burden of the neurological disorders, growing cancer cases and rising investment in oncology market, and minimal side effects of the radiopharmaceuticals as compared with its potential benefits. In addition, rising burden of the neurological disorders is anticipated to boost the growth of the market as well.

The radiopharmaceuticals market analysis includes application segment and geographic landscapes

Technavio's ‘ radiopharmaceuticals market ’ is segmented as below:

By Application:

  • Diagnostics
  • Therapeutic

By Geographic Landscape:

  • North America
  • Europe
  • APAC
  • South America
  • MEA

This study identifies the partnerships for development of radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, production based on cyclotron will lead to sizable demand in the market.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our radiopharmaceuticals market covers the following areas:

  • Radiopharmaceuticals market sizing
  • Radiopharmaceuticals market forecast
  • Radiopharmaceuticals market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, BWX Technologies Inc., Cardinal Health Inc., Curium, Eckert & Ziegler AG, Eli Lilly and Co., General Electric Co., Lantheus Holdings Inc., Novartis AG, and Siemens Healthineers AG. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Diagnostics - Market size and forecast 2019-2024
  • Therapeutic - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bayer AG
  • BWX Technologies Inc.
  • Cardinal Health Inc.
  • Curium
  • Eckert & Ziegler AG
  • Eli Lilly and Co.
  • General Electric Co.
  • Lantheus Holdings Inc.
  • Novartis AG
  • Siemens Healthineers AG

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ Million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Diagnostics - Market size and forecast 2019-2024 ($ Million)
  • 24: Diagnostics - Year-over-year growth 2019-2024 (%)
  • 25: Therapeutic - Market size and forecast 2019-2024 ($ Million)
  • 26: Therapeutic - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Application
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ Million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ Million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: APAC - Market size and forecast 2019-2024 ($ Million)
  • 36: APAC - Year-over-year growth 2019-2024 (%)
  • 37: South America - Market size and forecast 2019-2024 ($ Million)
  • 38: South America - Year-over-year growth 2019-2024 (%)
  • 39: MEA - Market size and forecast 2019-2024 ($ Million)
  • 40: MEA - Year-over-year growth 2019-2024 (%)
  • 41: Key leading countries
  • 42: Market opportunity by geography ($ Million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: Bayer AG - Overview
  • 50: Bayer AG - Business segments
  • 51: Bayer AG - Key offerings
  • 52: Bayer AG - Key customers
  • 53: Bayer AG - Segment focus
  • 54: BWX Technologies Inc. - Overview
  • 55: BWX Technologies Inc. - Business segments
  • 56: BWX Technologies Inc. - Key offerings
  • 57: BWX Technologies Inc. - Key customers
  • 58: BWX Technologies Inc. - Segment focus
  • 59: Cardinal Health Inc. - Overview
  • 60: Cardinal Health Inc. - Business segments
  • 61: Cardinal Health Inc. - Key offerings
  • 62: Cardinal Health Inc. - Key customers
  • 63: Cardinal Health Inc. - Segment focus
  • 64: Curium - Overview
  • 65: Curium - Product and service
  • 66: Curium - Key offerings
  • 67: Curium - Key customers
  • 68: Curium - Segment focus
  • 69: Eckert & Ziegler AG - Overview
  • 70: Eckert & Ziegler AG - Business segments
  • 71: Eckert & Ziegler AG - Key offerings
  • 72: Eckert & Ziegler AG - Key customers
  • 73: Eckert & Ziegler AG - Segment focus
  • 74: Eli Lilly and Co. - Overview
  • 75: Eli Lilly and Co. - Business segments
  • 76: Eli Lilly and Co. - Key offerings
  • 77: Eli Lilly and Co. - Key customers
  • 78: Eli Lilly and Co. - Segment focus
  • 79: General Electric Co. - Overview
  • 80: General Electric Co. - Business segments
  • 81: General Electric Co. - Key offerings
  • 82: General Electric Co. - Key customers
  • 83: General Electric Co. - Segment focus
  • 84: Lantheus Holdings Inc. - Overview
  • 85: Lantheus Holdings Inc. - Business segments
  • 86: Lantheus Holdings Inc. - Key offerings
  • 87: Lantheus Holdings Inc. - Key customers
  • 88: Lantheus Holdings Inc. - Segment focus
  • 89: Novartis AG - Overview
  • 90: Novartis AG - Business segments
  • 91: Novartis AG - Key offerings
  • 92: Novartis AG - Key customers
  • 93: Novartis AG - Segment focus
  • 94: Siemens Healthineers AG - Overview
  • 95: Siemens Healthineers AG - Business segments
  • 96: Siemens Healthineers AG - Key offerings
  • 97: Siemens Healthineers AG - Key customers
  • 98: Siemens Healthineers AG - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations